About this trial

Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.

Eligibility criteria

Qualifiers

Voluntary agreement to participate in the study

Clinical diagnosis of Parkinson's disease confirmed by a neurologist

Ongoing treatment with antiparkinsonian medication

Hoehn and Yahr (H-Y) stage ≤ 3

Disqualifiers

Presence of additional neurological disorders other than Parkinson's disease

Change in medication dosage within the past month

Score of ≥ 10 on the Simulator Sickness Questionnaire

Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision

Trial design

Treatments tested in this trial

  • Patient-Specific VR Action Observation Training
  • Healthy-Model VR Action Observation Training

Treatment groups

24 Participants
are divided into 2 treatment groups

Locations

1
Abant Izzet Baysal University Faculty of Health Science14100, BoluBolu, Turkey (Türkiye)

Sponsors and collaborators

Abant Izzet Baysal University

Lead sponsor